IBERE PHARMACEUTICALS [Rocket]

Date Filed	Type	Description
03/13/2023	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
03/02/2023	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
02/14/2023	SC 13G	GLAZER CAPITAL, LLC reports a 9.6% stake in Ibere Pharmaceuticals
02/14/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2023	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/12/2022	10-Q	Quarterly Report for the period ended June 30, 2022
05/16/2022	10-Q	Quarterly Report for the period ended March 31, 2022
03/31/2022	10-K	Annual Report for the period ended December 31, 2021
02/14/2022	SC 13G/A	CITADEL ADVISORS LLC reports a 5.6% stake in Ibere Pharmaceuticals
02/08/2022	SC 13G	PIPV Capital LLC reports a 20% stake in Ibere Pharmaceuticals
01/14/2022	SC 13G	Magnetar Financial LLC reports a 5.8% stake in IBERE PHARMACEUTICALS
11/12/2021	10-Q	Quarterly Report for the period ended September 30, 2021
09/27/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/16/2021	10-Q	Quarterly Report for the period ended June 30, 2021
08/16/2021	10-Q/A	Quarterly Report for the period ended March 31, 2021 [amend]
08/16/2021	8-K/A	Quarterly results
08/13/2021	8-K	Quarterly results
08/04/2021	8-K	Quarterly results
07/16/2021	10-Q	Quarterly Report for the period ended March 31, 2021
05/28/2021	8-K	Quarterly results
05/18/2021	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/12/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/08/2021	8-K	Quarterly results
03/03/2021	8-K	Quarterly results
03/01/2021	424B4	Form 424B4 - Prospectus [Rule 424(b)(4)]:
02/25/2021	S-1MEF	Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
02/25/2021	CERT	Form CERT - Certification by an exchange approving securities for listing:
02/25/2021	8-A12B	Form 8-A12B - Registration of securities [Section 12(b)]:
02/22/2021	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]